
via ACS
Going to the doctor might make you want to cry, and according to a new study, doctors could someday put those tears to good use.
In ACS Nano, researchers report a nanomembrane system that harvests and purifies tiny blobs called exosomes from tears, allowing researchers to quickly analyze them for disease biomarkers. Dubbed iTEARS, the platform could enable more efficient and less invasive molecular diagnoses for many diseases and conditions, without relying solely on symptoms.
Diagnosing diseases often hinges on assessing a patient’s symptoms, which can be unobservable at early stages, or unreliably reported. Identifying molecular clues in samples from patients, such as specific proteins or genes from vesicular structures called exosomes, could improve the accuracy of diagnoses. However, current methods for isolating exosomes from these samples require long, complicated processing steps or large sample volumes. Tears are well-suited for sample collection because the fluid can be collected quickly and non-invasively, though only tiny amounts can be harvested at a time. So, Luke Lee, Fei Liu and colleagues wondered if a nanomembrane system, which they originally developed for isolating exosomes from urine and plasma, could allow them to quickly obtain these vesicles from tears and then analyze them for disease biomarkers.
The team modified their original system to handle the low volume of tears. The new system, called “Incorporated Tear Exosomes Analysis via Rapid-isolation System” (iTEARS), separated out exosomes in just 5 minutes by filtering tear solutions over nanoporous membranes with an oscillating pressure flow to reduce clogging. Proteins from the exosomes could be tagged with fluorescent probes while they were still on the device and then transferred to other instruments for further analysis. Nucleic acids were also extracted from the exosomes and analyzed. The researchers successfully distinguished between healthy controls and patients with various types of dry eye disease based on a proteomic assessment of extracted proteins. Similarly, iTEARS enabled researchers to observe differences in microRNAs between patients with diabetic retinopathy and those that didn’t have the eye condition, suggesting that the system could help track disease progression. The team says that this work could lead to a more sensitive, faster and less invasive molecular diagnosis of various diseases — using only tears.
Original Article: ‘iTEARS’ could help diagnose diseases by isolating biomarkers in tears
More from: Wenzhou Medical University | American Chemical Society
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Biomarkers in tears
- Biomarker Algorithm May Predict Immunotherapy Outcomes Across Cancer Types
A new study has been published which validates the clinical utility of Immunotherapy Response Scores, a tool that can be used to predict which patients with cancer would benefit from single-agent ...
- Proteomic Approaches in Lung Cancer Biomarker Development
Considering the need for experiments to confirm the applicability of markers or drugs that are developed based on animal models or in vitro cell lines, identifying biomarkers directly from human ...
- Genetic Biomarkers in Acute Myeloid Leukemia
The use of prognostic biomarkers has allowed for a more detailed categorization of AML based on risk. Despite this tremendous progress, the understanding of the mechanisms by which these changes ...
- Biomarkers Market is expected to grow from USD 66.6 billion in 2022 to USD 183.42 billion by 2030 : GreyViews
These are the key regions where the biomarkers market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the biomarkers market are present across various ...
- The eyes have it: Your tears could foretell your ailments
A tear-based point-of-care diagnostic kit is being developed by researchers at GROW laboratory in Narayana Nethralaya eye hospital. If all goes as pla ...
Go deeper with Google Headlines on:
Biomarkers in tears
[google_news title=”” keyword=”biomarkers in tears” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Molecular diagnosis
- Study finds unique DMD disease mechanism, may help in diagnosis
New research revealed a disease mechanism in Duchenne muscular dystrophy that changes how genes are read, and may aid diagnosis and treatment.
- Molecular ALS subtypes linked to age of disease onset, survival
Three subtypes of ALS, each with a unique pattern of gene activity in patient brain tissue, were associated with clinical outcomes.
- Iloilo City to convert old molecular facility into diagnostic lab
The city government here will be converting its old molecular laboratory into an Uswag Iloilo City Clinical Laboratory and Diagnostic Center to provide free services to city hall employees and ...
- India in the midst of molecular diagnostic revolution with technologies for accurate detection & rapid turnaround
India in the midst of molecular diagnostic revolution with technologies for accurate detection & rapid turnaround: Nandita Vijay, Bengaluru Tuesday, February 7, 2023, 08:00 Hrs [I ...
- Faster genomics-based diagnosis may accelerate targeted treatment of patients with myeloid neoplasms
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients. However, treatment initiation can be delayed by the ...
Go deeper with Google Headlines on:
Molecular diagnosis
[google_news title=”” keyword=”molecular diagnosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]